Global Liver Cancer Therapeutics Market Outlook 2025–2034: Growth, Trends & Forecast

The global liver cancer therapeutics market, valued at USD 2.50 billion in 2024, is expected to grow at a CAGR of 19.85%, reaching USD 15.29 billion by 2034. This growth is driven by the rising prevalence of liver cancer and the increasing demand for more effective and innovative treatment options. Advancements in therapeutic modalities and expanding access to treatments across global markets are expected to drive significant market growth during the forecast period.